$PTLA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PORTOLA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PORTOLA PHARMACEUTICALS INC. Get notifications about new insider transactions in PORTOLA PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 ... 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 05 2019 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Sell | M | 27.55 | 2,000 | 55,104 | 0 | 2 K to 0 (-100.00 %) |
| May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Option Exercise | M | 0.00 | 5,859 | 0 | 0 | |
| May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Payment of Exercise | F | 28.69 | 3,022 | 86,701 | 69,570 | 72.6 K to 69.6 K (-4.16 %) |
| May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Grant | A | 0.00 | 5,859 | 0 | 72,592 | 66.7 K to 72.6 K (+8.78 %) |
| May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Option Exercise | M | 0.00 | 4,688 | 0 | 0 | |
| May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Payment of Exercise | F | 28.69 | 903 | 25,907 | 101,656 | 102.6 K to 101.7 K (-0.88 %) |
| May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Payment of Exercise | F | 28.69 | 2,418 | 69,372 | 102,559 | 105 K to 102.6 K (-2.30 %) |
| May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Grant | A | 0.00 | 1,750 | 0 | 104,977 | 103.2 K to 105 K (+1.70 %) |
| May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Grant | A | 0.00 | 4,688 | 0 | 103,227 | 98.5 K to 103.2 K (+4.76 %) |
| Apr 16 2019 | PTLA | PORTOLA PHARMACEUT ... | RENTON HOLLINGS | Director | Option Exercise | M | 9.00 | 5,000 | 45,000 | 15,000 | |
| Apr 16 2019 | PTLA | PORTOLA PHARMACEUT ... | RENTON HOLLINGS | Director | Sell | S | 35.07 | 400 | 14,027 | 9,000 | 9.4 K to 9 K (-4.26 %) |
| Apr 16 2019 | PTLA | PORTOLA PHARMACEUT ... | RENTON HOLLINGS | Director | Sell | S | 34.40 | 4,600 | 158,223 | 9,400 | 14 K to 9.4 K (-32.86 %) |
| Apr 16 2019 | PTLA | PORTOLA PHARMACEUT ... | RENTON HOLLINGS | Director | Buy | M | 9.00 | 5,000 | 45,000 | 14,000 | 9 K to 14 K (+55.56 %) |
| Apr 08 2019 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Sell | S | 37.39 | 40,486 | 1,513,824 | 66,733 | 107.2 K to 66.7 K (-37.76 %) |
| Apr 01 2019 | PTLA | PORTOLA PHARMACEUT ... | HOMCY CHARLES J | Option Exercise | A | 33.59 | 10,000 | 335,900 | 10,000 | ||
| Mar 14 2019 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | M | 5.10 | 5,000 | 25,500 | 0 | |
| Mar 14 2019 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Buy | M | 5.10 | 5,000 | 25,500 | 15,766 | 10.8 K to 15.8 K (+46.44 %) |
| Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Brame Glenn P | EVP, CTOO | Option Exercise | A | 27.10 | 60,000 | 1,626,000 | 60,000 | |
| Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Brame Glenn P | EVP, CTOO | Grant | A | 0.00 | 15,000 | 0 | 40,000 | 25 K to 40 K (+60.00 %) |
| Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Meyer Ernie | EVP and CHRO | Option Exercise | A | 27.10 | 75,000 | 2,032,500 | 75,000 | |
| Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Meyer Ernie | EVP and CHRO | Grant | A | 0.00 | 18,750 | 0 | 48,750 | 30 K to 48.8 K (+62.50 %) |
| Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Moriarty John B | EVP, General Counse ... | Option Exercise | A | 27.10 | 75,000 | 2,032,500 | 75,000 | |
| Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Moriarty John B | EVP, General Counse ... | Grant | A | 0.00 | 18,750 | 0 | 43,750 | 25 K to 43.8 K (+75.00 %) |
| Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Option Exercise | A | 27.10 | 18,000 | 487,800 | 18,000 | |
| Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Grant | A | 0.00 | 4,500 | 0 | 104,985 | 100.5 K to 105 K (+4.48 %) |
| Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Option Exercise | A | 27.10 | 75,000 | 2,032,500 | 75,000 | |
| Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Grant | A | 0.00 | 18,750 | 0 | 116,682 | 97.9 K to 116.7 K (+19.15 %) |
| Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Option Exercise | A | 27.10 | 120,400 | 3,262,840 | 120,400 | |
| Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Grant | A | 0.00 | 30,100 | 0 | 155,100 | 125 K to 155.1 K (+24.08 %) |
| Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Koenig Sheldon L. | EVP, Chief Commerci ... | Option Exercise | A | 27.10 | 125,000 | 3,387,500 | 125,000 | |
| Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Koenig Sheldon L. | EVP, Chief Commerci ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Jan 15 2019 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Payment of Exercise | F | 24.25 | 868 | 21,049 | 97,932 | 98.8 K to 97.9 K (-0.88 %) |
| Jan 15 2019 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Grant | A | 0.00 | 2,125 | 0 | 98,800 | 96.7 K to 98.8 K (+2.20 %) |
| Jan 15 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Payment of Exercise | F | 24.25 | 715 | 17,339 | 100,485 | 101.2 K to 100.5 K (-0.71 %) |
| Jan 15 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Grant | A | 0.00 | 1,750 | 0 | 101,200 | 99.5 K to 101.2 K (+1.76 %) |
| Jan 04 2019 | PTLA | PORTOLA PHARMACEUT ... | HOMCY CHARLES J | Director | Option Exercise | M | 5.10 | 11,481 | 58,553 | 0 | |
| Jan 04 2019 | PTLA | PORTOLA PHARMACEUT ... | HOMCY CHARLES J | Director | Option Exercise | M | 5.10 | 14,835 | 75,659 | 0 | |
| Jan 04 2019 | PTLA | PORTOLA PHARMACEUT ... | HOMCY CHARLES J | Director | Option Exercise | M | 5.10 | 19,607 | 99,996 | 0 | |
| Jan 04 2019 | PTLA | PORTOLA PHARMACEUT ... | HOMCY CHARLES J | Director | Buy | M | 5.10 | 45,923 | 234,207 | 165,403 | 119.5 K to 165.4 K (+38.44 %) |
| Dec 19 2018 | PTLA | PORTOLA PHARMACEUT ... | HOMCY CHARLES J | Director | Option Exercise | M | 4.10 | 25,782 | 105,706 | 0 | |
| Dec 19 2018 | PTLA | PORTOLA PHARMACEUT ... | HOMCY CHARLES J | Director | Option Exercise | M | 4.10 | 39,828 | 163,295 | 25,782 | |
| Dec 19 2018 | PTLA | PORTOLA PHARMACEUT ... | HOMCY CHARLES J | Director | Option Exercise | M | 4.10 | 24,390 | 99,999 | 0 | |
| Dec 19 2018 | PTLA | PORTOLA PHARMACEUT ... | HOMCY CHARLES J | Director | Buy | M | 4.10 | 25,782 | 105,706 | 119,480 | 93.7 K to 119.5 K (+27.52 %) |
| Dec 19 2018 | PTLA | PORTOLA PHARMACEUT ... | HOMCY CHARLES J | Director | Sell | S | 19.20 | 700 | 13,440 | 112,471 | 113.2 K to 112.5 K (-0.62 %) |
| Dec 19 2018 | PTLA | PORTOLA PHARMACEUT ... | HOMCY CHARLES J | Director | Sell | S | 18.60 | 63,518 | 1,181,562 | 113,171 | 176.7 K to 113.2 K (-35.95 %) |
| Dec 19 2018 | PTLA | PORTOLA PHARMACEUT ... | HOMCY CHARLES J | Director | Buy | M | 4.10 | 64,218 | 263,294 | 176,689 | 112.5 K to 176.7 K (+57.10 %) |
| Nov 16 2018 | PTLA | PORTOLA PHARMACEUT ... | HOMCY CHARLES J | Director | Option Exercise | M | 4.10 | 93,698 | 384,162 | 65,610 | |
| Nov 16 2018 | PTLA | PORTOLA PHARMACEUT ... | HOMCY CHARLES J | Director | Buy | M | 4.10 | 93,698 | 384,162 | 93,698 | 0 to 93.7 K |
| Oct 31 2018 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Option Exercise | A | 19.69 | 250,000 | 4,922,500 | 250,000 | |
| Oct 31 2018 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Grant | A | 0.00 | 125,000 | 0 | 125,000 | 0 to 125 K |
| Sep 05 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Interim Co-Presiden ... | Payment of Exercise | F | 29.18 | 8,884 | 259,203 | 98,800 | 107.7 K to 98.8 K (-8.25 %) |
| Sep 05 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Interim Co-Presiden ... | Buy | M | 0.00 | 17,500 | 0 | 107,684 | 90.2 K to 107.7 K (+19.40 %) |
| Sep 05 2018 | PTLA | PORTOLA PHARMACEUT ... | Fu Tao | EVP, CBO | Payment of Exercise | F | 29.18 | 10,153 | 296,228 | 77,043 | 87.2 K to 77 K (-11.64 %) |
| Sep 05 2018 | PTLA | PORTOLA PHARMACEUT ... | Fu Tao | EVP, CBO | Buy | M | 0.00 | 20,000 | 0 | 87,196 | 67.2 K to 87.2 K (+29.76 %) |
| Sep 05 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Interim Co-Presiden ... | Payment of Exercise | F | 29.18 | 8,884 | 259,203 | 101,200 | 110.1 K to 101.2 K (-8.07 %) |
| Sep 05 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Interim Co-Presiden ... | Buy | M | 0.00 | 17,500 | 0 | 110,084 | 92.6 K to 110.1 K (+18.90 %) |
| Sep 05 2018 | PTLA | PORTOLA PHARMACEUT ... | Meyer Ernie | EVP and CHRO | Option Exercise | A | 29.85 | 87,500 | 2,611,875 | 87,500 | |
| Sep 05 2018 | PTLA | PORTOLA PHARMACEUT ... | Meyer Ernie | EVP and CHRO | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
| Aug 28 2018 | PTLA | PORTOLA PHARMACEUT ... | Lis William | Chief Executive Off ... | Payment of Exercise | F | 26.05 | 17,587 | 458,141 | 204,448 | 222 K to 204.4 K (-7.92 %) |
| Aug 28 2018 | PTLA | PORTOLA PHARMACEUT ... | Lis William | Chief Executive Off ... | Buy | M | 0.00 | 35,000 | 0 | 222,035 | 187 K to 222 K (+18.71 %) |
| Aug 28 2018 | PTLA | PORTOLA PHARMACEUT ... | Fu Tao | EVP, CBO | Payment of Exercise | F | 26.05 | 2,057 | 53,585 | 87,196 | 89.3 K to 87.2 K (-2.30 %) |
| Aug 28 2018 | PTLA | PORTOLA PHARMACEUT ... | Fu Tao | EVP, CBO | Buy | M | 0.00 | 5,000 | 0 | 89,253 | 84.3 K to 89.3 K (+5.93 %) |
| Aug 28 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Interim Co-Presiden ... | Payment of Exercise | F | 26.05 | 8,794 | 229,084 | 107,477 | 116.3 K to 107.5 K (-7.56 %) |
| Aug 28 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Interim Co-Presiden ... | Buy | M | 0.00 | 17,500 | 0 | 116,271 | 98.8 K to 116.3 K (+17.72 %) |
| Aug 28 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Interim Co-Presiden ... | Payment of Exercise | F | 26.05 | 8,171 | 212,855 | 110,084 | 118.3 K to 110.1 K (-6.91 %) |
| Aug 28 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Interim Co-Presiden ... | Buy | M | 0.00 | 17,500 | 0 | 118,255 | 100.8 K to 118.3 K (+17.37 %) |
| Aug 23 2018 | PTLA | PORTOLA PHARMACEUT ... | BIRD JEFFREY W | Director | Buy | P | 26.65 | 50,355 | 1,341,810 | 449,053 | 398.7 K to 449.1 K (+12.63 %) |
| Aug 23 2018 | PTLA | PORTOLA PHARMACEUT ... | BIRD JEFFREY W | Director | Buy | P | 26.09 | 202,082 | 5,273,006 | 398,698 | 196.6 K to 398.7 K (+102.78 %) |
| Aug 23 2018 | PTLA | PORTOLA PHARMACEUT ... | BIRD JEFFREY W | Director | Buy | P | 25.17 | 137,563 | 3,462,571 | 196,616 | 59.1 K to 196.6 K (+232.95 %) |
| Jul 06 2018 | PTLA | PORTOLA PHARMACEUT ... | Brame Glenn P | SVP, Technical Oper ... | Option Exercise | A | 37.77 | 87,500 | 3,304,875 | 87,500 | |
| Jul 06 2018 | PTLA | PORTOLA PHARMACEUT ... | Brame Glenn P | SVP, Technical Oper ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Jun 11 2018 | PTLA | PORTOLA PHARMACEUT ... | BIRD JEFFREY W | Director | Option Exercise | A | 42.81 | 6,000 | 256,860 | 6,000 | |
| Jun 11 2018 | PTLA | PORTOLA PHARMACEUT ... | BIRD JEFFREY W | Director | Grant | A | 0.00 | 3,000 | 0 | 9,000 | 6 K to 9 K (+50.00 %) |
| Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | RENTON HOLLINGS | Director | Option Exercise | A | 42.81 | 6,000 | 256,860 | 6,000 | |
| Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | RENTON HOLLINGS | Director | Grant | A | 0.00 | 3,000 | 0 | 9,000 | 6 K to 9 K (+50.00 %) |
| Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | HOMCY CHARLES J | Director | Option Exercise | A | 42.81 | 6,000 | 256,860 | 6,000 | |
| Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | HOMCY CHARLES J | Director | Grant | A | 0.00 | 3,000 | 0 | 115,471 | 112.5 K to 115.5 K (+2.67 %) |
| Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | A | 42.81 | 6,000 | 256,860 | 6,000 | |
| Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Grant | A | 0.00 | 3,000 | 0 | 10,766 | 7.8 K to 10.8 K (+38.63 %) |
| Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | STUMP DAVID C | Director | Option Exercise | A | 42.81 | 6,000 | 256,860 | 6,000 | |
| Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | STUMP DAVID C | Director | Grant | A | 0.00 | 3,000 | 0 | 9,000 | 6 K to 9 K (+50.00 %) |
| Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | Lis William | Chief Executive Off ... | Sell | S | 45.21 | 5,113 | 231,159 | 222,035 | 227.1 K to 222 K (-2.25 %) |
| Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Option Exercise | A | 42.81 | 6,000 | 256,860 | 6,000 | |
| Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Grant | A | 0.00 | 3,000 | 0 | 9,000 | 6 K to 9 K (+50.00 %) |
| Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | FENTON DENNIS M | Director | Option Exercise | A | 42.81 | 6,000 | 256,860 | 6,000 | |
| Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | FENTON DENNIS M | Director | Grant | A | 0.00 | 3,000 | 0 | 9,000 | 6 K to 9 K (+50.00 %) |
| Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | Brege Laura | Director | Option Exercise | A | 42.81 | 6,000 | 256,860 | 6,000 | |
| Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | Brege Laura | Director | Grant | A | 0.00 | 3,000 | 0 | 9,000 | 6 K to 9 K (+50.00 %) |
| May 24 2018 | PTLA | PORTOLA PHARMACEUT ... | Lis William | Chief Executive Off ... | Payment of Exercise | F | 40.82 | 6,491 | 264,963 | 227,148 | 233.6 K to 227.1 K (-2.78 %) |
| May 24 2018 | PTLA | PORTOLA PHARMACEUT ... | Lis William | Chief Executive Off ... | Grant | A | 0.00 | 12,890 | 0 | 233,639 | 220.7 K to 233.6 K (+5.84 %) |
| May 24 2018 | PTLA | PORTOLA PHARMACEUT ... | Fu Tao | EVP, CBO | Payment of Exercise | F | 40.82 | 2,059 | 84,048 | 89,253 | 91.3 K to 89.3 K (-2.25 %) |
| May 24 2018 | PTLA | PORTOLA PHARMACEUT ... | Fu Tao | EVP, CBO | Grant | A | 0.00 | 5,859 | 0 | 91,312 | 85.5 K to 91.3 K (+6.86 %) |
| May 24 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Payment of Exercise | F | 40.82 | 2,514 | 102,621 | 116,271 | 118.8 K to 116.3 K (-2.12 %) |
| May 24 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Grant | A | 0.00 | 5,859 | 0 | 118,785 | 112.9 K to 118.8 K (+5.19 %) |
| May 24 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Payment of Exercise | F | 40.82 | 1,647 | 67,231 | 118,255 | 119.9 K to 118.3 K (-1.37 %) |
| May 24 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Grant | A | 0.00 | 4,687 | 0 | 119,902 | 115.2 K to 119.9 K (+4.07 %) |
| Mar 30 2018 | PTLA | PORTOLA PHARMACEUT ... | Moriarty John B | EVP, General Counse ... | Option Exercise | A | 32.66 | 125,000 | 4,082,500 | 125,000 | |
| Mar 30 2018 | PTLA | PORTOLA PHARMACEUT ... | Moriarty John B | EVP, General Counse ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Mar 14 2018 | PTLA | PORTOLA PHARMACEUT ... | Fu Tao | EVP, CBO | Sell | S | 38.47 | 1,135 | 43,663 | 18,346 | 19.5 K to 18.3 K (-5.83 %) |
| Mar 14 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | M | 8.50 | 5,049 | 42,917 | 0 | |
| Mar 14 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Buy | M | 8.50 | 5,049 | 42,917 | 5,049 | 0 to 5 K |
| Mar 12 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Sell | D | 39.16 | 2,009 | 78,667 | 61,442 | 63.5 K to 61.4 K (-3.17 %) |
| Mar 12 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Sell | D | 38.69 | 10,465 | 404,865 | 63,451 | 73.9 K to 63.5 K (-14.16 %) |
| Mar 06 2018 | PTLA | PORTOLA PHARMACEUT ... | Lis William | Chief Executive Off ... | Payment of Exercise | F | 32.53 | 19,184 | 624,056 | 70,624 | 89.8 K to 70.6 K (-21.36 %) |
| Mar 06 2018 | PTLA | PORTOLA PHARMACEUT ... | Fu Tao | EVP, CBO | Payment of Exercise | F | 32.53 | 5,041 | 163,984 | 27,498 | 32.5 K to 27.5 K (-15.49 %) |
| Mar 06 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Payment of Exercise | F | 32.53 | 6,735 | 219,090 | 31,040 | 37.8 K to 31 K (-17.83 %) |
| Mar 06 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Payment of Exercise | F | 32.53 | 4,530 | 147,361 | 22,499 | 27 K to 22.5 K (-16.76 %) |
| Feb 02 2018 | PTLA | PORTOLA PHARMACEUT ... | Lawrence John H III | SVP, Chief Medical ... | Option Exercise | A | 51.31 | 27,500 | 1,411,025 | 27,500 | |
| Feb 02 2018 | PTLA | PORTOLA PHARMACEUT ... | Lawrence John H III | SVP, Chief Medical ... | Grant | A | 0.00 | 6,875 | 0 | 6,875 | 0 to 6.9 K |
| Feb 02 2018 | PTLA | PORTOLA PHARMACEUT ... | Fu Tao | EVP, CBO | Option Exercise | A | 51.31 | 35,000 | 1,795,850 | 35,000 | |
| Feb 02 2018 | PTLA | PORTOLA PHARMACEUT ... | Fu Tao | EVP, CBO | Grant | A | 0.00 | 8,750 | 0 | 8,750 | 0 to 8.8 K |
| Feb 02 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | A | 51.31 | 42,500 | 2,180,675 | 42,500 | |
| Feb 02 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Grant | A | 0.00 | 10,625 | 0 | 10,625 | 0 to 10.6 K |
| Feb 02 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | A | 51.31 | 35,000 | 1,795,850 | 35,000 | |
| Feb 02 2018 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Grant | A | 0.00 | 8,750 | 0 | 8,750 | 0 to 8.8 K |
| Feb 02 2018 | PTLA | PORTOLA PHARMACEUT ... | Lis William | Chief Executive Off ... | Option Exercise | A | 51.31 | 100,000 | 5,131,000 | 100,000 | |
| Feb 02 2018 | PTLA | PORTOLA PHARMACEUT ... | Lis William | Chief Executive Off ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Dec 18 2017 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | M | 5.30 | 12,000 | 63,600 | 0 | |
| Dec 18 2017 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Sell | S | 47.77 | 700 | 33,438 | 0 | 700 to 0 (-100.00 %) |
| Dec 18 2017 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Sell | S | 46.95 | 11,300 | 530,512 | 700 | 12 K to 700 (-94.17 %) |
| Dec 18 2017 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Buy | M | 5.30 | 12,000 | 63,600 | 12,000 | 0 to 12 K |
| Dec 01 2017 | PTLA | PORTOLA PHARMACEUT ... | Lawrence John H III | SVP, Chief Medical ... | Option Exercise | A | 50.75 | 125,000 | 6,343,750 | 125,000 | |
| Dec 01 2017 | PTLA | PORTOLA PHARMACEUT ... | Lawrence John H III | SVP, Chief Medical ... | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Oct 06 2017 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | M | 5.30 | 12,000 | 63,600 | 0 | |
| Oct 06 2017 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Buy | M | 5.30 | 12,000 | 63,600 | 12,000 | 0 to 12 K |
| Sep 29 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | M | 7.00 | 14,285 | 99,995 | 0 | |
| Sep 29 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | M | 8.50 | 6,715 | 57,078 | 5,049 | |
| Sep 29 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Buy | M | 7.00 | 14,285 | 99,995 | 14,285 | 0 to 14.3 K |
| Sep 29 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Buy | M | 8.50 | 6,715 | 57,078 | 6,715 | 0 to 6.7 K |
| Aug 18 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Payment of Exercise | F | 54.86 | 2,644 | 145,050 | 0 | 2.6 K to 0 (-100.00 %) |
| Aug 18 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Payment of Exercise | F | 54.86 | 3,635 | 199,416 | 0 | 3.6 K to 0 (-100.00 %) |
| Aug 18 2017 | PTLA | PORTOLA PHARMACEUT ... | Fu Tao | EVP, CBO | Payment of Exercise | F | 54.86 | 1,991 | 109,226 | 0 | 2 K to 0 (-100.00 %) |
| Aug 18 2017 | PTLA | PORTOLA PHARMACEUT ... | Lis William | Chief Executive Off ... | Payment of Exercise | F | 54.86 | 7,435 | 407,884 | 0 | 7.4 K to 0 (-100.00 %) |
| Jul 20 2017 | PTLA | PORTOLA PHARMACEUT ... | Fu Tao | EVP, CBO | Option Exercise | M | 33.49 | 5,812 | 194,644 | 2,917 | |
| Jul 20 2017 | PTLA | PORTOLA PHARMACEUT ... | Fu Tao | EVP, CBO | Sell | S | 65.00 | 5,812 | 377,780 | 0 | 5.8 K to 0 (-100.00 %) |
| Jul 20 2017 | PTLA | PORTOLA PHARMACEUT ... | Fu Tao | EVP, CBO | Buy | M | 33.49 | 5,812 | 194,644 | 5,812 | 0 to 5.8 K |
| Jul 20 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Option Exercise | M | 8.50 | 10,000 | 85,000 | 1,918 | |
| Jul 20 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Sell | S | 65.00 | 10,000 | 650,000 | 0 | 10 K to 0 (-100.00 %) |
| Jul 20 2017 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | Executive Vice Pres ... | Buy | M | 8.50 | 10,000 | 85,000 | 10,000 | 0 to 10 K |
| Jul 14 2017 | PTLA | PORTOLA PHARMACEUT ... | BIRD JEFFREY W | Director | Option Exercise | A | 35.06 | 6,000 | 210,360 | 6,000 | |
| Jul 14 2017 | PTLA | PORTOLA PHARMACEUT ... | BIRD JEFFREY W | Director | Grant | A | 0.00 | 3,000 | 0 | 6,000 | 3 K to 6 K (+100.00 %) |
| Jul 13 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 25.08 | 23,350 | 585,618 | 35,390 | |
| Jul 13 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Sell | S | 60.00 | 23,350 | 1,401,000 | 0 | 23.4 K to 0 (-100.00 %) |
| Jul 13 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 25.08 | 23,350 | 585,618 | 23,350 | 0 to 23.4 K |
| Jun 29 2017 | PTLA | PORTOLA PHARMACEUT ... | Lis William | Chief Executive Off ... | Option Exercise | M | 9.00 | 14,150 | 127,350 | 101,820 | |
| Jun 29 2017 | PTLA | PORTOLA PHARMACEUT ... | Lis William | Chief Executive Off ... | Option Exercise | M | 9.80 | 20,000 | 196,000 | 69,796 | |
| Jun 29 2017 | PTLA | PORTOLA PHARMACEUT ... | Lis William | Chief Executive Off ... | Option Exercise | M | 7.00 | 70,014 | 490,098 | 0 | |
| Jun 29 2017 | PTLA | PORTOLA PHARMACEUT ... | Lis William | Chief Executive Off ... | Option Exercise | M | 7.00 | 14,285 | 99,995 | 0 | |
| Jun 29 2017 | PTLA | PORTOLA PHARMACEUT ... | Lis William | Chief Executive Off ... | Option Exercise | M | 8.50 | 55,000 | 467,500 | 2,070 | |
| Jun 29 2017 | PTLA | PORTOLA PHARMACEUT ... | Lis William | Chief Executive Off ... | Option Exercise | M | 9.00 | 95,850 | 862,650 | 115,970 |